PRLB
Get informed when a big investor buys or sells
+ FollowOvervalued by 69.4% based on the discounted cash flow analysis.
| Market cap | $2.12 Billion |
|---|---|
| Enterprise Value | $1.99 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.89 |
| Beta | 1.38 |
| Outstanding Shares | 23,902,802 |
| P/E Ratio | 70.01 |
|---|---|
| PEG | 65.59 |
| Price to Sales | 4.01 |
| Price to Book Ratio | 3.3 |
| Enterprise Value to Revenue | 3.55 |
| Enterprise Value to EBIT | 52.29 |
| Enterprise Value to Net Income | 65 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 27.24%▼ 65.66% |
|---|---|
| Total Invested | $529.11M▼ 57.94% |
| Investors Holding | 104▼ 162.00% |
No data
Protolabs is a company that provides rapid manufacturing of low-volume 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and short-run production. Markets like medical devices, electronics, applianc...